Large generation of megakaryocytes from serum-free expanded human CD34+ cells

被引:25
作者
Chen, Te-Wei [1 ]
Yao, Chao-Ling [1 ]
Chu, I-Ming [2 ]
Chuang, Tzu-Lin [1 ]
Hsieh, Tzu-Bou [1 ]
Hwang, Shiaw-Min [1 ]
机构
[1] Food Ind Res & Dev Inst, Bioresource Collect & Res Ctr, Hsinchu 30062, Taiwan
[2] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan
关键词
Hematopoietic stem cells; Megakaryocytes; Induction; Serum-free; UMBILICAL-CORD BLOOD; EX-VIVO EXPANSION; HEMATOPOIETIC STEM-CELLS; IN-VITRO; PLATELET PRODUCTION; PROGENITORS; MATURATION; LIGAND;
D O I
10.1016/j.bbrc.2008.11.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ex vivo generation of megakaryocytes from hematopoietic stem cells (HSCs) is crucial to HSC research and has important clinical potential for thrombocytopenia patients to rapid platelet reconstruction. In this study, factorial design and steepest ascent method were used to screen and optimize the effective cytokines (10.2 ng/ml TPO, 4.3 ng/ml IL-3, 15.0 ng/ml SCF, 5.6 ng/ml IL-6, 2.8 ng/ml FL, 2.8 ng/ml IL-9, and 2.8 ng/ml GM-CSF) in megakaryocyte induction medium that facilitate ex vivo megakaryopoiesis from CD34(+) cells. After induction, the maximum fold expansion for accumulated megakaryocytes was almost 5000-fold, and the induced megakaryocytes were characterized by analysis of gene expression, polyploidy and platelet activation ability. Furthermore, the combination of megakaryocyte induction medium and HSC expansion medium can induce and expand a large Amount of functional megakaryocytes efficiently, and might be a promising source of megakaryocytes and platelets for cell therapy in the future. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:112 / 117
页数:6
相关论文
共 25 条
[1]   Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer [J].
Basser, RL ;
Rasko, JEJ ;
Clarke, K ;
Cebon, J ;
Green, MD ;
Hussein, S ;
Alt, C ;
Menchaca, D ;
Tomita, D ;
Marty, J ;
Fox, RM ;
Begley, CG .
LANCET, 1996, 348 (9037) :1279-1281
[2]   Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients [J].
Bertolini, F ;
Battaglia, M ;
Pedrazzoli, P ;
DaPrada, GA ;
Lanza, A ;
Soligo, D ;
Caneva, L ;
Sarina, B ;
Murphy, S ;
Thomas, T ;
dellaCuna, GR .
BLOOD, 1997, 89 (08) :2679-2688
[3]  
BRIDDELL RA, 1991, BLOOD, V78, P2854
[4]  
BRUNO E, 1989, EXP HEMATOL, V17, P1038
[5]   Fast but durable megakaryocyte repopulation and platelet production in NOD/SCID mice transplanted with ex-vivo expanded human cord blood CD34+ cells [J].
Bruno, S ;
Gunetti, M ;
Gammaitoni, L ;
Perissinotto, E ;
Caione, L ;
Sanavio, F ;
Fagioli, F ;
Aglietta, M ;
Piacibello, W .
STEM CELLS, 2004, 22 (02) :135-143
[6]  
Bruno S, 2003, HAEMATOLOGICA, V88, P379
[7]   Placental and/or umbilical cord blood: An alternative source of hematopoietic stem cells for transplantation [J].
Cairo, MS ;
Wagner, JE .
BLOOD, 1997, 90 (12) :4665-4678
[8]   Efficient in vitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design [J].
Cortin, V ;
Garnier, A ;
Pineault, N ;
Lemieux, R ;
Boyer, L ;
Proulx, C .
EXPERIMENTAL HEMATOLOGY, 2005, 33 (10) :1182-1191
[9]   Role of human interleukin-9 as a megakaryocyte potentiator in culture [J].
Fujiki, H ;
Kimura, T ;
Minamiguchi, H ;
Harada, S ;
Wang, JF ;
Nakao, M ;
Yokota, SH ;
Urata, YJ ;
Ueda, YJ ;
Yamagishi, H ;
Sonoda, Y .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (12) :1373-1380
[10]   Platelets [J].
George, JN .
LANCET, 2000, 355 (9214) :1531-1539